Inhibin/activin betaB-subunit expression in pheochromocytomas favors benign diagnosis.

Salmenkivi, K; Arola, J; Voutilainen, R; Ilvesmäki, V; Haglund, C; Kahri, A I; Heikkilä, P; Liu, J

Salmenkivi, K; Arola, J; Voutilainen, R; Ilvesmäki, V; Haglund, C; Kahri, A I; Heikkilä, P; Liu, J.

Affiliation

Salmenkivi K; Department of Pathology, Haartman Institute, University of Helsinki, Finland. kaisa.salmenkivi@helsinki.fi

J Clin Endocrinol Metab ; 86(5): 2231-5, 2001 May.

Article in En | MEDLINE | ID: mdl-11344232

Subject(s)

Activins; Adrenal Gland Neoplasms/chemistry; Inhibin-beta Subunits; Inhibins/analysis; Peptides/analysis; Pheochromocytoma/chemistry; Adolescent; Adult; Aged; Blotting, Northern; Female; Humans; Immunohistochemistry; Inhibins/genetics; Male; Middle Aged; Peptides/genetics; RNA, Messenger/analysis

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Pheochromocytoma / Adrenal Gland Neoplasms / Activins / Inhibin-beta Subunits / Inhibins Type of study: Diagnostic_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Endocrinol Metab Year: 2001 Type: Article Affiliation country: Finland

Search on Google

XML

PubMed Links